2m 2m 2m 2m 2m 2m 2m
Macrogenics (MGNX)
NASDAQ
$4.15+$0.10 (+2.47%)
Price as of Jun 03, 2026 7:59 PM EDT- $264.4MMarket Cap
- 168.21%1-Year Change
- BiotechnologyIndustry
Macrogenics (MGNX)
$4.15+$0.10 (+2.47%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 118.9M +102.31% | 58.7M -61.33% | 151.9M +96.19% | |
Cost of Revenue | 0 -100.00% | 847,000 +36.83% | 619,000 -81.53% | 3.4M +26.41% | |
Gross Profit | 0 -100.00% | 118.0M +103.01% | 58.1M -60.88% | 148.6M +98.66% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -147.2M -16.94% | -177.2M +6.37% | -166.6M -19.54% | -207.0M -3.52% | |
Depreciation and Amortization Expense | 7.2M -4.88% | 7.5M -21.82% | 9.6M -18.71% | 11.9M +5.39% | |
Total Operating Expenses | 222.3M -14.66% | 260.5M +14.78% | 227.0M -16.96% | 273.4M -2.46% | |
Operating Profit | -72.8M -34.13% | -110.6M -34.28% | -168.2M +38.57% | -121.4M -40.13% | |
Interest Income | 3.4M -39.29% | 5.6M +40.00% | 4.0M +135.29% | 1.7M -15.00% | |
Interest Expense | N/A N/A | -1.1M -22.03% | -1.4M N/A | N/A N/A | |
Interest Income and Expense and Net | 3.4M -24.19% | 4.5M +74.51% | 2.6M +51.18% | 1.7M -15.00% | |
Total Nonoperating Income and Expense | 6.1M -35.71% | 9.4M -2.74% | 9.7M +483.49% | 1.7M +144.12% | |
Income before Taxes | -75.3M +14.04% | -66.0M -60.76% | -168.2M +38.57% | -121.4M -40.13% | |
Income Taxes | -672,000 -171.19% | 944,000 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -74.6M +11.43% | -67.0M +639.30% | -9.1M -92.44% | -119.8M -40.75% | |
Net Income from Continuing Operations Applicable to Common | -75.3M +14.04% | -66.0M +628.88% | -9.1M -92.44% | -119.8M -40.75% | |
Basic EPS and Net Income | -1.18 +10.28% | -1.07 +613.33% | -0.15 -92.31% | -1.95 N/A | |
Diluted EPS and Net Income | -1.18 +10.28% | -1.07 +613.33% | -0.15 -92.31% | -1.95 N/A | |
Basic Weighted Average Shares | 63.2M +0.85% | 62.6M +1.12% | 61.9M +0.81% | 61.4M +2.48% | |
Diluted Weighted Average Shares | 63.2M +0.85% | 62.6M +1.12% | 61.9M +0.81% | 61.4M +2.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 57.2M -68.71% | 182.8M +81.11% | 101.0M -7.28% | 108.9M -11.81% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 57.2M -68.71% | 182.8M +81.11% | 101.0M -7.28% | 108.9M -11.81% | |
Total Current Assets | 219.9M +1.13% | 217.5M -13.47% | 251.3M +13.12% | 222.2M -20.53% | |
Accumulated Depreciation | 95.8M +8.03% | 88.7M +0.33% | 88.4M +5.12% | 84.1M +15.49% | |
Property and Plant and Equipment and Net | 12.6M -30.25% | 18.1M -17.15% | 21.8M -26.13% | 29.6M -21.50% | |
Total Long-Term Assets | 1.4M -10.99% | 1.6M +12.27% | 1.4M +0.58% | 1.4M -92.35% | |
Total Assets | 256.8M -1.84% | 261.7M -12.32% | 298.4M +6.40% | 280.5M -16.34% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 43.1M -22.36% | 55.5M -1.03% | 56.1M +15.42% | 48.6M -34.82% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.1M -46.54% | 2.0M +662.79% | 258,000 0.00% | 258,000 0.00% | |
Total Liabilities | 201.3M +38.23% | 145.6M -0.14% | 145.8M +5.31% | 138.5M +44.79% | |
Retained Earnings | -1.2B +6.38% | -1.2B +6.07% | -1.1B +0.83% | -1.1B +12.30% | |
Total Stockholders Equity | 55.6M -52.10% | 116.1M -23.95% | 152.6M +7.46% | 142.0M -40.73% | |
Total Shares Outstanding | 63.3M +0.79% | 62.8M +1.21% | 62.1M +0.60% | 61.7M +0.64% | |
Cash Flow | |||||
Cash from Operating Activities | -81.0M +18.53% | -68.4M -12.57% | -78.2M -10.07% | -87.0M -39.54% | |
Capital Expenditures | 1.9M -48.35% | 3.7M +110.09% | 1.8M -51.31% | 3.6M -41.57% | |
Cash from Investing Activities | -114.1M -176.42% | 149.3M +286.43% | -80.1M -213.25% | 70.7M +293.16% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 69.5M +7,141.04% | 960,000 -99.36% | 150.4M +8,963.35% | 1.7M -98.65% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 99.29% +0.34% | 98.95% +1.18% | 97.79% +1.26% | |
Operating Margin | N/A N/A | -93.04% -67.51% | -286.38% +258.37% | -79.91% -69.48% | |
Return on Assets | -28.78% +20.36% | -23.91% +664.13% | -3.13% -91.96% | -38.90% -31.29% | |
Return on Equity | -86.95% +74.41% | -49.85% +710.73% | -6.15% -90.20% | -62.76% -16.86% | |
Revenue Growth | -100.00% -197.74% | 102.31% +266.81% | -61.33% -163.77% | 96.19% +467.71% | |
Current Ratio | 5.10 +30.25% | 3.92 -12.57% | 4.48 -1.99% | 4.57 +21.93% | |
Cash Ratio | 1.33 -59.69% | 3.29 +82.99% | 1.80 -19.67% | 2.24 +35.29% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow